Engagement of high-affinity immunoglobulin E receptors (FceRI) activates two signaling pathways in mast cells. The Lyn pathway leads to recruitment of Syk and to calcium mobilization whereas the Fyn pathway leads to phosphatidylinositol 3-kinase recruitment. Mapping the connections between both pathways remains an important task to be completed. We previously reported that Phospholipid Scramblase 1 (PLSCR1) is phosphorylated on tyrosine after cross-linking FceRI on RBL-2H3 rat mast cells, amplifies mast cell degranulation, and is associated with both Lyn and Syk tyrosine kinases. Here, analysis of the pathway leading to PLSCR1 tyrosine phosphorylation reveals that it depends on the FcRc chain. FceRI aggregation in Fyn-deficient mouse bone marrow-derived mast cells (BMMC) induced a more robust increase in FceRI-dependent tyrosine phosphorylation of PLSCR1 compared to wild-type cells, whereas PLSCR1 phosphorylation was abolished in Lyn-deficient BMMC. Lyn association with PLSCR1 was not altered in Fyn-deficient BMMC. PLSCR1 phosphorylation was also dependent on the kinase Syk and significantly, but partially, dependent on detectable calcium mobilization. Thus, the Lyn/Syk/calcium axis promotes PLSCR1 phosphorylation in multiple ways. Conversely, the Fyn-dependent pathway negatively regulates it. This study reveals a complex regulation for PLSCR1 tyrosine phosphorylation in FceRI-activated mast cells and that PLSCR1 sits at a crossroads between Lyn and Fyn pathways. 
Introduction
High-affinity receptors for IgE (FceRI) expressed on mast cells promote, after their aggregation by IgE and antigen, the release of preformed mediators stored in cytoplasmic granules and of newly synthesized lipid mediators and cytokines [1] . Engagement of FceRI leads to the activation of at least two signaling pathways. One is initiated by the tyrosine kinase Lyn [2] and leads to recruitment of another tyrosine kinase, Syk, to the receptor and to activation of the signaling complex recruited by the protein adaptor LAT [3] , resulting in calcium mobilization [4] . The other pathway, initiated by the tyrosine kinase Fyn [4] , leads to phosphatidylinositol 3-kinase recruitment [4, 5] . Both pathways cooperate to determine the extent of degranulation and of cytokine and lipid inflammatory mediator production. It has been demonstrated that the Lyn-initiated pathway negatively regulates the Fyn-initiated pathway through recruitment of the kinase Csk [6] . Since the FceRI-dependent cell activation combines these pathways into one coherent signal, mapping of their connections is an important task that remains to be completed to fully understand signal integration.
Recently, we reported that phospholipid scramblase 1 (PLSCR1) is phosphorylated on tyrosine after aggregation of FceRI on mast cells [7] . PLSCR1 is a multi-function protein. It was originally identified based on its capacity to accelerate transbilayer migration of phospholipids upon interaction with calcium, thereby collapsing the lipid asymmetry existing between inner and outer leaflets of plasma membranes [8, 9] . Activation of scrambling leads to increased cell surface exposure of phosphatidylserine and other aminophospholipids. This has been implicated in the recognition of apoptotic cells by phagocytes and in the cell surface expression of procoagulant activity by activated platelets and perturbed endothelium [10, 11] . Interestingly, activated mast cells also demonstrate transient exposure of phosphatidylserine [12, 13] . However, studies with knock-out mice questioned the involvement of PLSCR1 alone in phospholipid scrambling [14, 15] . Recently, several reports have implicated the Ca 2+ -activated ion channels belonging to the TMEM16 family in phospholipid scrambling induced by a calcium ionophore [16] [17] [18] . By contrast, phospholipid scrambling following caspase activation during apoptosis was shown to be promoted by Xkr8, a putative transporter [19] . Therefore, depending on the triggering signal, phospholipid scrambling now appears to result from a variety of alternative mechanisms, in which the specific role of plasma membrane PLSCR1 remains to be resolved. In addition to its putative role in mediating transbilayer movement of plasma membrane phospholipids that accompanies PS exposure at the cell surface, there is now also considerable evidence that: i) PLSCR1 serves as a signaling intermediate for the Epidermal Growth Factor (EGF) receptor promoting optimal activation of p60c-Src [20, 21] ; ii) PLSCR1 contains a nuclear localisation signal domain that mediates nuclear trafficking of the unpalmitoylated form of the protein [22, 23] ; iii) de novo synthesis of PLSCR1 is induced by interferon-a (IFNa) and results in its nuclear trafficking and binding to chromosomal DNA [23] [24] [25] . In this setting, PLSCR1 may serve as a transcription factor since it amplifies the expression of IFNa/b-stimulated genes [26] and promotes the transcription of the inositol 1, 4, 5-trisphosphate receptor gene [27] ; iv) PLSCR1 potentiates granulopoiesis by prolonging expansion of granulocyte precursors presumably through its role in transcriptional regulation [15] ; v) Expression of PLSCR1 has been shown to be tumor suppressive, and its level of expression in bone marrow cells to correlate with long-term survival in acute myelogenous leukemia, whereas mutations affecting PLSCR1 appear to promote the leukemogenic potential of myeloid progenitors [28] [29] [30] [31] ; vi) PLSCR1 regulates compensatory endocytosis in neuroendocrine cells [32] ; vii) PLSCR1 is capable of potentiating a select set of mast cell responses following FceRI aggregation [33] . In this study, we observed that endogenous expression of PLSCR1 in RBL-2H3 mast cells doubles VEGF production and the degranulation response to FceRI engagement as compared to PLSCR1-knock-down RBL-2H3 cells, without any detectable impact on MCP-1 production and release of arachidonic acid metabolites. In PLSCR1-knocked-down RBL-2H3 cells the LAT-PLCc-calcium axis initiated by Lyn was inhibited [33] . Interestingly, Lyn was found to colocalize with PLSCR1 at the cell membrane and to coprecipitate with it. Syk, which is downstream of Lyn activation, was also found to interact with PLSCR1 [33] .
Whereas the kinase responsible for the tyrosine phosphorylation of PLSCR1 after engagement of the EGF receptor has been identified as p60c-Src [20, 21] , and as c-Abl after induction of apoptosis [34] , the regulatory pathway leading to PLSCR1 tyrosine phosphorylation after FceRI aggregation remains to be elucidated. The present study was carried out to identify this pathway. We found that the Lyn and Fyn pathways cooperate in FceRI-dependent tyrosine phosphorylation of PLSCR1. Indeed, PLSCR1 phosphorylation was dependent on FcRc chain, on Lyn and on Syk and partially on intracellular calcium mobilization, suggesting direct involvement of both kinases through a direct association with PLSCR1, and indirectly as a result of calcium mobilization. We also provide evidence that Fyn negatively regulates PLSCR1 tyrosine phosphorylation.
Materials and Methods

Ethics statement
Mice were maintained and used in accordance with NIH guidelines and Animal Study Proposals approved by the NIAMS Animal Care and Use Committee (ASP number AO12-11-01).
Antibodies and reagents
The anti-DNP monoclonal IgE DNP-48 [35] was a kind gift of Dr. Reuben Siraganian (NIH, Bethesda, MD). The monoclonal anti-rat PLSCR1 antibody 129.2 was produced in the laboratory [7, 36] . Monoclonal anti-mouse PLSCR1 antibody 1A8 has been described elsewhere [20] . Anti-Lyn and anti-Fyn polyclonal antibodies were from Santa-Cruz Biotech (Santa-Cruz, CA). Anti-phosphotyrosine monoclonal antibody 4G10 was used as a culture supernatant of the 4G10 hybridoma or as horseraddish peroxidase (HRP)-coupled antibody (Calbiochem, La Jolla, CA). HRP-labeled secondary antibodies (rabbit anti-mouse and goat anti-rabbit) were from Sigma-Aldrich (St-Louis, MO). Cell culture medium (D-MEM and E-MEM), fetal calf serum and other culture reagents were from Gibco-BRL-Life Technologies (Gaithersburg, MD). Triton X-100 and sodium dodecyl sulfate (SDS), bovine serum albumin (BSA), DNP-human serum albumin (DNP-HSA), proteases and phosphatases inhibitors (leupeptin and aprotinin, NaF and Na 3 VO 4 ) were from Sigma-Aldrich (St-Louis, MO). G418 was from PAA Laboratories (Les Mureaux, France).
Cells and cell lines
The RBL-2H3 [37] or the b-hexosaminidase high-releaser subclone 9 of this cell line were maintained in culture as described [13] . The Syk-deficient RBL-2H3 variant and the Syk reconstituted clone have been described elsewhere [38] and were generously provided by Dr. Reuben P. Siraganian (NIDCR, NIH, Bethesda, MD). The Syk reconstituted clone was maintained in selective medium containing 1 mg/ml G418.
RBL-2H3 transfectants expressing either the wild-type FcaRI or the mutated R209L FcaRI have been described elsewhere and express equivalent levels of the transfected receptor [39] . Whereas the wild-type FcaRI does associate with endogenous FcRc chain, the mutated R209L FcaRI does not, as determined by coimmunoprecipitation experiments [39] . These transfectants were maintained in selective medium containing 1 mg/ml G418.
Bone marrow-derived mast cells (BMMC) were obtained from Lyn-deficient, Fyn-deficient, Lyn/Fyn double deficient or wildtype control mice [4] . After sacrifice of the mice by CO 2 inhalation, bone marrow cells were cultured in RPMI-1640 containing 16% fetal calf serum, glutamax, non-essential amino acids, streptomycin and penicillin, and supplemented with 20 ng/ ml interleukin-3 and 20 ng/ml Stem Cell Factor (both from Peprotech, Rocky Hill, NJ). After four weeks in culture more than 95% of the cells were mast cells as assessed by FceRI and c-kit expression and toluidine blue staining.
Reconstitution experiments
A lentiviral approach was used that was essentially as previously described [40] . The lentiviral vectors carried Lyn kinase or the catalytically inactive form of Lyn (K172R). The forward and reverse primer sequences used to insert a point mutation in the kinase domain of Lyn (Lyn K172R) were as follows: 59-GTGGCTGTGAGGACCCTCA- 39 (forward), 59-CTTGAGGGTCCTCACAGCC-39 (reverse). For stimulation of FcaRI transfectants (wild-type and R209L mutated proteins), cells were first incubated with 10 mg/ml F(ab')2 fragment of the anti-FcaRI monoclonal antibody A77 [41] for 1 hr at 4uC in Tyrode's buffer. Cells were then washed twice and stimulated for the indicated time at 37uC with 20 mg/ml F(ab')2 fragment of rabbit anti-mouse IgG antibody.
Cell stimulation and lysis
In all experiments, the supernatant was recovered for control of degranulation and cells were washed in ice-cold PBS. Cells were lysed on ice in 200 ml lysis solution (Hepes 50 mM pH 7.2, 50 mM NaF, 50 mM NaCl, 1 mM Na 3 VO 4 , 1% Triton X-100, 0.1% SDS, 10 mg/ml leupeptin, 10 mg/ml aprotinin). After 10 min on ice, the wells were scraped, their content transferred to microtubes and the soluble cell lysates were recovered following centrifugation at 14,000 g for 10 minutes at 4uC for immunoblotting or immunoprecipitation. For co-immunoprecipitation purposes, 1610 7 cells were lysed in 500 ml lysis buffer containing 0.5% Triton X-100.
Imumunoprecipitation and immunoblotting
Proteins in the soluble cell lysates were immunoprecipitated with either Sepharose-4B (Pharmacia, Uppsala, Sweden) coupled antibodies (for 129.2, and control IgG) or with anti-mouse PLSCR1 monoclonal antibody 1A8 adsorbed to protein G beads (Pharmacia, Uppsala, Sweden), by incubation in a rotating wheel for 2 hours (hr) at 4uC. Beads were washed 6 times with 1 ml icecold lysis buffer and material was eluted by boiling for 5 min in Laemmli sample buffer [42] .
Immunoblots were performed after resolution of proteins by SDS-PAGE and their transfer onto PVDF membranes. After blocking non specific sites by incubation for 1 hr in 10 mM Tris pH 7.2 containing 150 mM NaCl, 0.05% Tween 20 and 4% BSA, membranes were incubated with the desired first antibody for 1 hr, washed 3 times for 10 min, incubated with the relevant secondary antibody and washed 3 times for 10 min. Blots were revealed by incubation in SuperSignal West Pico solution from Pierce (Rockford, IL) and exposure to X-OMAT films from Kodak (Rochester, NY). In some cases, membranes were stripped by several washes in methanol and reblotted with control antibodies. Blots were quantified by densitometry using the National Institutes of Health Software Image J 1.46r after scanning of the films. In the case of PLSCR1 the band corresponding to phosphorylated PLSCR1 was normalized to the total PLSCR1 protein recovered in the precipitates for each experimental point. Fold phosphorylation is the ratio of the corrected value of phospho-PLSCR1 obtained with stimulated cells to that obtained with the non-stimulated cells.
Degranulation measurements
Degranulation was assessed by measurement of the release of the granule marker b-hexosaminidase as described [43] .
Calcium measurement
RBL-2H3 cells were trypsinized and washed two times in culture medium. Cells were then sensitized in the presence 1:10 
Statistical analyses
All experiments were conducted at least three times (see figure legends). Statistical analyses were performed using GraphPad Prism 5.0 as indicated in figure legends.
Results
IgE-mediated PLSCR1 tyrosine phosphorylation is dependent on the FcRc chain
The tetrameric form of FceRI is composed of one FceRIa chain responsible for IgE binding, and of the signal transducing chains FceRIb and a dimer of FcRc (ab(c) 2 ). The FcRc chain is also mandatory for FceRI cell membrane expression. We first examined whether this chain was required for the signal leading to PLSCR1 tyrosine phosphorylation. The FcRc chain is shared by many Fc receptors [44] including the receptor for IgA (FcaRI) [45, 46] . Interestingly, this receptor cannot associate with the FcRc chain when an arginine-to-leucine (R209L) mutation is introduced in its transmembrane domain but is readily expressed at the plasma membrane [39] . Since mast cells do not express FcaRI, we took advantage of RBL-2H3 rat mast cells that had been transfected with wild-type or mutant (R209L) FcaRI. Of note, these transfectants expressed comparable levels of FcaRI at the plasma membrane and engagement of wild-type FcaRI induced degranulation of the transfectants whereas aggregation of of the R209L mutant did not ( [47] and data not shown). As in the parental cell line, aggregation of FceRI in these transfectants resulted in PLSCR1 tyrosine phosphorylation ( figure 1 ). Yet, whereas tyrosine phosphorylation of PLSCR1 was readily observed after aggregation of wild-type FcaRI, no such phosphorylation could be detected after engagement of the FcaRI R209L mutated form of FcaRI (figure 1). We conclude that PLSCR1 phosphorylation required the FcRc chain.
IgE-mediated PLSCR1 tyrosine phosphorylation depends on Lyn
It is well established that Lyn [2] and Fyn [4] , both Src-family kinase members, function immediately downstream of the receptor. To determine which one of these kinases was important for PLSCR1 tyrosine phosphorylation, we used bone marrowderived mast cells (BMMC) from Lyn-deficient and from Fyndeficient mice. As a first step, FceRI-dependent tyrosine phosphorylation of PLSCR1 was examined in wild-type BMMC. An increased phosphorylation was observed as soon as 30 sec after FceRI engagement and reached a plateau after 9 min stimulation (Figure 2A) confirming that the phosphorylation observed in RBL-2H3 rat mast cells was not the result of the tumoral phenotype of this cell line and that it was not restricted to rat mast cells. Therefore in all BMMC experiments, subsequent analyses were performed after at least 9 minutes of stimulation. As in RBL-2H3 cells [7] phospho-PLSCR1 migrated as a heterogeneous band between 37 and 48 kDa (Figure 2A) . We first assessed the involvement of Lyn in the PLSCR1 tyrosine phosphorylation by using BMMC from Lyn 2/2 mice. Interestingly, no increase in tyrosine phosphorylation of PLSCR1 was observed in these cells after FceRI aggregation ( Figure 2B ). Reconstitution of the Lyn 2/2 cells with kinase-sufficient Lyn restored PLSCR1 tyrosine phosphorylation. By contrast, reconstitution with kinase-deficient Lyn was unable to restore this phosphorylation. These results show that Lyn is mandatory and its kinase activity is required for FceRIdependent increase in PLSCR1 phosphorylation.
IgE-mediated PLSCR1 tyrosine phosphorylation is negatively regulated by Fyn
Surprisingly, the increased tyrosine phosphorylation of PLSCR1 after FceRI engagement was higher in Fyn-deficient BMMC (Figure 3 ), revealing that Fyn is a negative regulator for this event. This more robust increase in PLSCR1 phosphorylation was also dependent on Lyn. No increased PLSCR1 phosphorylation was observed in BMMC deficient for both Lyn and Fyn (Figure 4) suggesting that Fyn impedes the Lyn-dependent PLSCR1 phosphorylation rather than targeting an altogether different pathway. This led us to examine whether Fyn deficiency had an impact on the expression of Lyn or of PLSCR1, or on their association. There was no difference in Lyn or PLSCR1 expression between wild-type and Fyn-deficient BMMC (Figure 5A) . As well, co-immunoprecipitation experiments demonstrated that the absence of Fyn did not result in a detectable increase in Lyn association with PLSCR1 ( Figure 5B ), although it confirmed in BMMC an association between Lyn and PLSCR1 that was not modulated by FceRI aggregation as we previously reported in RBL-2H3 cells [33] . We conclude that Lyn-dependent and Fyn-dependent signals converge as antagonists in the regulation of FceRI-mediated PLSCR1 tyrosine phosphorylation.
IgE-mediated PLSCR1 tyrosine phosphorylation depends on Syk
Syk is a tyrosine kinase that is activated downstream of Lyn [1] and that coprecipitates with PLSCR1 [38] . Therefore, we used a variant of RBL-2H3 that is deficient in Syk [38] to evaluate its involvement in PLSCR1 phosphorylation. Aggregation of FceRI on these cells resulted in no significant increase in tyrosine phosphorylation of PLSCR1 ( Figure 6 ). Reconstitution of these cells with Syk restored in great part the FceRI-induced tyrosine phosphorylation of PLSCR1 ( Figure 6 ). These data demonstrate that Syk is required for optimal FceRI-dependent phosphorylation of PLSCR1.
IgE-mediated PLSCR1 tyrosine phosphorylation is partially dependent on intracellular calcium mobilization
Calcium mobilization occurs downstream of Lyn and of Syk activation in FceRI-activated mast cells [4, 38] , and FceRI engagement induces both early (calcium independent) and late (calcium dependent) tyrosine phosphorylations [48] . PLSCR1 has an EF-hand-like domain allowing calcium binding that results in a conformational change of the molecule [49] [50] [51] . In addition, calcium ionophores can induce PLSCR1 tyrosine phosphorylation [52] . Therefore, we examined whether FceRI-dependent phosphorylation of PLSCR1 is modulated by calcium mobilization that occurs in response to activation of this receptor. To that effect, RBL-2H3 cells were activated in the presence extracellular calcium, or in cells loaded with the intracellular calcium-chelator BAPTA-AM and suspended in calcium-free medium. In the absence of calcium (and in the presence of BAPTA-AM), aggregation of FceRI induced a detectable increase in tyrosine phosphorylation of PLSCR1. Yet, this increase amounted to approximately 25% of that observed after FceRI aggregation in the presence of calcium ( figure 7A ). Under these conditions, and as previously reported [53] , no degranulation (figure 7B) and no detectable calcium signal (figure 7C) were observed. Although one cannot completely exclude that infinitesimal or highly localised variations of free cytosolic calcium could account for the residual tyrosine phosphorylation of PLSCR1 in the absence of external calcium and in the presence of BAPTA, our data strongly indicate collectively that IgE-mediated PLSCR1 phosphorylation involves calcium-dependent and calcium-independent signals.
Discussion
We previously reported that PLSCR1 is phosphorylated on tyrosine after aggregation of FceRI expressed on the RBL-2H3 rat mast cell line [7] . Background levels of PLSCR1 tyrosine phosphorylation before receptor engagement varied from experiment to experiment but could be seen in all cases upon sufficient exposure time of immunoblots. This was true not only for RBL cells, but also for BMMC. We believe that these variations might be related to variations in batch-to-batch cell cultures as we routinely observed variations in cell growth intensity and in degranulation responses of BMMC. However, a statistical increase in PLSCR1 tyrosine phosphorylation was reproducibly observed after aggregation of the receptor in WT BMMC. The data presented here demonstrate that this phosphorylation is subject to regulation that involves calcium mobilization as well as both positive and negative regulatory mechanisms mediated by Lyn and Syk, and Fyn, respectively (summarized in Figure 8 ). These data suggest that the phosphorylation of PLSCR1 is pivotal to the crossinteraction of the Lyn-and Fyn-initiated signaling pathways. Whereas initial analyses of FceRI-dependent signaling pathways concentrated on defining specific effectors for each pathway, it becomes increasingly evident that multiple signals converge and that cross-talk of signals is key for an integrated cellular response. Example of this is provided by the tyrosine kinase Csk and by the adaptor Cbp that are recruited by Lyn and that negatively regulate the Fyn signaling in FceRI-mediated mast cell activation [6] . Therefore, whereas Lyn can negatively regulate Fyn-initiated signals [6] , herein we report that, conversely, Fyn can negatively regulate at least some Lyn-initiated signals, demonstrating that both pathways have the capacity to control each other. Thus, particular substrates could function at such crossroads promoting integration of signaling pathways and allowing fine-tuning and regulation. Interestingly, we previously demonstrated that PLSCR1 acts as an amplifier of the LAT-PLCc-calcium axis thus modulating degranulation and VEGF production [33] . This axis depends on the Lyn-initiated signaling pathway. The association between Lyn and PLSCR1 is reminiscent of the association between PLSCR1 and Src in EGF receptor signaling that potentiates Src kinase activity [20, 21] . Our present study demonstrates that whereas PLSCR1 can modulate the Lyn initiated pathway, this pathway controls PLSCR1 tyrosine phosphorylation, revealing a particular partnership between PLSCR1 and Lyn in FceRI-induced mast cell activation. The absolute requirement of Lyn and Syk is demonstrated by the absence of FceRI-dependent increase in PLSCR1 phosphorylation in mast cells deficient for either kinase. Of note, absence of either kinase abolishes the mobilization of calcium [4, 38] . Yet, we observed a residual, but significant, increase in tyrosine phosphorylation of PLSCR1 in the absence of calcium after FceRI aggregation. This indicates that PLSCR1 could be phosphorylated on multiple tyrosines (calcium-dependent and calcium-independent), which would be in agreement with the heterogeneous molecular weight observed for phospho-PLSCR1 in mast cells, although the extent of this heterogeneity varies somehow from experiment to experiment for reasons that remain so far unclear. The increase in PLSCR1 tyrosine phosphorylation observed in the presence of calcium may be due to its phosphorylation on additional phosphorylation sites accessible after the conformational change induced by calcium [49, 50] . Alternatively, new molecules of PLSCR1 could be recruited for tyrosine phosphorylation by the same or other kinases.
That Lyn and Syk could be directly involved in the phosphorylation of PLSCR1 is supported by several observations. Lyn and Syk were found to physically interact with PLSCR1 [33] . In addition, the FceRI-dependent tyrosine phosphorylation of PLSCR1 was fully ablated in the absence of FcRc, and partially in the absence of calcium, mapping the occurrence of the residual increase in the phosphorylation of PLSCR1 upstream of the calcium signal but downstream of the FcRc chain, i.e. where Lyn and Syk are thought to function in IgE-mediated signaling [1] . Moreover, tyrosine phosphorylation of PLSCR1 was recovered when Lyn 2/2 BMMC and Syk-deficient RBL-2H3 cells were reconstituted with kinase competent Lyn or Syk, respectively, demonstrating that the defect in PLSCR1 phosphorylation was not due to aberrant maturation of these cells but to a kinase-related defect in FceRI signaling. After FceRI aggregation no significant increase in Lyn association with PLSCR1 was observed indicating that tyrosine phosphorylation of PLSCR1 by Lyn is not solely regulated by the interaction between both proteins but might be also regulated by Lyn activation. Previous studies have demonstrated that PLSCR1 also interacts with the prototypic kinase p60c-src within the EGF receptor signaling pathways [20, 21] , thus serving as a substrate for p60c-src and, in turn, amplifying the activation of this kinase [20] . These data together with the ones collected herein, suggest a preferred connection between PLSCR1 and this family of tyrosine kinases that might be due to their common localization at the plasma membrane and particularly in lipid rafts [21, 33] .
This preferred connection is also highlighted by the negative regulation of PLSCR1 tyrosine phosphorylation by Fyn, another member of the Src family. This was revealed by the more robust increase in FceRI-dependent phosphorylation of PLSCR1 in Fyndeficient BMMC. The increased phosphorylation of PLSCR1 was not due to an increased calcium signal because Fyn deficiency does not increase this signal [4] . Neither was it due to an overall increase in tyrosine phosphorylation of cellular proteins since tyrosine phosphorylation of proteins in whole cell lysates from activated cells is significantly lower in Fyn-deficient BMMC compared to their wild-type counterparts ( [4] and data not shown).
The data presented here extend our original observation that rat PLSCR1 is phosphorylated on tyrosine after FceRI aggregation in the RBL-2H3 mast cell line [7] to non-tumoral mast cells derived in culture (BMMC) and to another species. Furthermore, the demonstration that it is initiated by the FcRc chain and by another FcRc-associated receptor (the transfected FcaRI) suggests that other Fc receptors should be able to promote the tyrosine phosphorylation of PLSCR1. The complexity of the mechanisms regulating PLSCR1 tyrosine phosphorylation suggests that this phosphorylation might play an important role in the regulation of PLSCR1 amplifier function. Studies by others have reported that there is no correlation between mast cell degranulation, phosphatidylserine externalization and tyrosine phosphorylation of PLSCR1 when comparing mast cells stimulated through FceRI, Thy-1 and calcium ionophores [52] . The evidence presented here suggesting that PLSCR1 is phosphorylated on multiple tyrosines raises the possibility that positive regulation of degranulation by PLSCR1 may be associated with its phosphorylation on particular tyrosines whereas phosphorylation of other tyrosines may be Figure 8 . Complex regulation of FceRI-dependent tyrosine phosphorylation of PLSCR1. Based on the data presented herein, we propose that tyrosine phosphorylation of PLSCR1 following FceRI engagement is regulated on at least three levels in mast cells. Positive regulation is mediated by the Lyn-dependent pathway, whereas negative regulation is mediated by the Fyn-dependent pathway. After FceRI aggregation, PLSCR1 can be phosphorylated on tyrosine directly either by Lyn or by Syk and indirectly as a result of Lyn/Syk-dependent activation of subsequent calcium mobilization. The other activation pathway initiated by FceRI, that is dependent on Fyn, negatively regulates tyrosine phosphorylation of PLSCR1. Whether it acts by directly modulating Lyn-mediated or calcium-dependent tyrosine phosphorylation of PLSCR1, by controlling the PLSCR1 cellular localization required for its optimal phosphorylation by the Lyn pathway or by promoting its dephosphorylation is still unresolved. doi:10.1371/journal.pone.0109800.g008
